150 related articles for article (PubMed ID: 22832236)
1. Cholinergic deficit and response to donepezil therapy in Parkinson's disease with dementia.
Hiraoka K; Okamura N; Funaki Y; Hayashi A; Tashiro M; Hisanaga K; Fujii T; Takeda A; Yanai K; Iwata R; Mori E
Eur Neurol; 2012; 68(3):137-43. PubMed ID: 22832236
[TBL] [Abstract][Full Text] [Related]
2. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
Dubois B; Tolosa E; Katzenschlager R; Emre M; Lees AJ; Schumann G; Pourcher E; Gray J; Thomas G; Swartz J; Hsu T; Moline ML
Mov Disord; 2012 Sep; 27(10):1230-8. PubMed ID: 22915447
[TBL] [Abstract][Full Text] [Related]
3. Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.
Gjerløff T; Fedorova T; Knudsen K; Munk OL; Nahimi A; Jacobsen S; Danielsen EH; Terkelsen AJ; Hansen J; Pavese N; Brooks DJ; Borghammer P
Brain; 2015 Mar; 138(Pt 3):653-63. PubMed ID: 25539902
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
[TBL] [Abstract][Full Text] [Related]
5. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
[TBL] [Abstract][Full Text] [Related]
6. The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.
Müller T; Welnic J; Fuchs G; Baas H; Ebersbach G; Reichmann H
J Neural Transm Suppl; 2006; (71):27-30. PubMed ID: 17447412
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
Gu C; Shen T; An H; Yuan C; Zhou J; Ye Q; Liu T; Wang X; Zhang T
Neurosci Lett; 2015 Oct; 606():13-7. PubMed ID: 26297124
[TBL] [Abstract][Full Text] [Related]
8. Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.
Rowan E; McKeith IG; Saxby BK; O'Brien JT; Burn D; Mosimann U; Newby J; Daniel S; Sanders J; Wesnes K
Dement Geriatr Cogn Disord; 2007; 23(3):161-7. PubMed ID: 17192712
[TBL] [Abstract][Full Text] [Related]
9. Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.
Ishikawa K; Motoi Y; Mizuno Y; Kubo S; Hattori N
Psychogeriatrics; 2014 Jun; 14(2):93-100. PubMed ID: 24661498
[TBL] [Abstract][Full Text] [Related]
10. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
[TBL] [Abstract][Full Text] [Related]
11. The effect of donepezil on increased regional cerebral blood flow in the posterior cingulate cortex of a patient with Parkinson's disease dementia.
Imamura K; Wada-Isoe K; Kowa H; Tanabe Y; Nakashima K
Neurocase; 2008; 14(3):271-5. PubMed ID: 18645736
[TBL] [Abstract][Full Text] [Related]
12. Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.
Ceravolo R; Volterrani D; Frosini D; Bernardini S; Rossi C; Logi C; Manca G; Kiferle L; Mariani G; Murri L; Bonuccelli U
J Neural Transm (Vienna); 2006 Nov; 113(11):1787-90. PubMed ID: 16758132
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses.
Gjerløff T; Jakobsen S; Nahimi A; Munk OL; Bender D; Alstrup AK; Vase KH; Hansen SB; Brooks DJ; Borghammer P
J Nucl Med; 2014 Nov; 55(11):1818-24. PubMed ID: 25324520
[TBL] [Abstract][Full Text] [Related]
14. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
15. Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series.
Doyle RL; Frazier J; Spencer TJ; Geller D; Biederman J; Wilens T
J Atten Disord; 2006 Feb; 9(3):543-9. PubMed ID: 16481671
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of therapeutic response to donepezil by positron emission tomography.
Shimada A; Hashimoto H; Kawabe J; Higashiyama S; Kai T; Kataoka K; Tagawa R; Kawarada Y; Nakanishi A; Inoue K; Shiomi S; Kiriike N
Osaka City Med J; 2011 Jun; 57(1):11-9. PubMed ID: 22106763
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic and perfusion brain networks in Parkinson disease dementia.
Colloby SJ; McKeith IG; Burn DJ; Wyper DJ; O'Brien JT; Taylor JP
Neurology; 2016 Jul; 87(2):178-85. PubMed ID: 27306636
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of donepezil binding to acetylcholinesterase using positron emission tomography and [5-(11)C-methoxy]donepezil.
Hiraoka K; Okamura N; Funaki Y; Watanuki S; Tashiro M; Kato M; Hayashi A; Hosokai Y; Yamasaki H; Fujii T; Mori E; Yanai K; Watabe H
Neuroimage; 2009 Jul; 46(3):616-23. PubMed ID: 19286462
[TBL] [Abstract][Full Text] [Related]
19. Donepezil for dementia with Lewy bodies: a case study.
Aarsland D; Brønnick K; Karlsen K
Int J Geriatr Psychiatry; 1999 Jan; 14(1):69-72. PubMed ID: 10029938
[No Abstract] [Full Text] [Related]
20. The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia.
Werber EA; Rabey JM
J Neural Transm (Vienna); 2001; 108(11):1319-25. PubMed ID: 11768630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
